Displaying drugs 14926 - 14950 of 15538 in total
GliSODin
Investigational
Nutraceutical
Darleukin
Investigational
MTI-201
Investigational
Algenpantucel-L
Investigational
GTA002
Investigational
CE-VST01-JC
Investigational
KITE-222
Investigational
DP-303c
Investigational
Murlentamab
Investigational
Lerapolturev
Investigational
ALT-P7
Investigational
G100
Investigational
ST-36
ST-36 is a cell-penetrating dominant-negative form of activating transcription factor 5. In 2017, it received orphan drug designation by the FDA for the treatment of glioma.
Investigational
LV305
LV305 is a lentiviral vector encoding NY-ESO-1 gene. LV305 is an active component of CMB305 along with G305.
Investigational
Leuvectin
Leuvectin (formerly known as VCL-1102) is a component of gene therapy along with cationic lipid 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE).
Investigational
KTH-222
Investigational
Belzupacap Sarotalocan
Investigational
ADXS-31164
Investigational
Eltrapuldencel-T
Investigational
Inalimarev
Investigational
IMGN779
Investigational
ICG-140
Investigational
Displaying drugs 14926 - 14950 of 15538 in total